Ligand validation:1MQM

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 1MQM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1MQM_NAG_G_401	25%	48%	0.275	0.915	0.74	1.28	-	2	0	0	100%	0.9333
1MQM_NAG_D_400	23%	25%	0.215	0.837	1.17	2.02	2	4	0	0	100%	0.9333
1MQM_NAG_G_406	19%	48%	0.278	0.872	0.86	1.14	1	1	6	0	100%	0.9333
1MQM_NAG_B_400	6%	59%	0.423	0.868	0.66	0.9	-	1	0	0	100%	0.9333
1MQM_NAG_E_400	5%	66%	0.455	0.872	0.6	0.67	-	-	0	0	100%	0.9333
1MQM_NAG_A_400	4%	61%	0.42	0.787	0.72	0.75	-	1	0	0	100%	0.9333
1MQM_NAG_H_400	3%	36%	0.489	0.836	1.32	1.26	3	2	2	0	100%	0.9333
1MQM_NAG_D_401	3%	41%	0.471	0.814	0.93	1.4	1	3	0	0	100%	0.9333
1MQM_NAG_G_400	3%	17%	0.447	0.763	1.22	2.56	1	5	4	0	100%	0.9333
5K9Q_NAG_F_201	94%	88%	0.076	0.974	0.2	0.47	-	-	0	0	100%	0.9333
4O58_NAG_A_503	68%	36%	0.148	0.96	0.57	2.02	-	3	0	0	100%	0.9333
5KAN_NAG_C_401	62%	87%	0.131	0.922	0.2	0.5	-	-	0	0	100%	0.9333
1HGE_NAG_E_334	60%	48%	0.147	0.934	0.82	1.18	-	1	0	0	100%	0.9333
6BKM_NAG_E_506	60%	49%	0.131	0.916	0.63	1.34	-	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.